Informationen:
Fehler:
ID
19703
Beschreibung
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00415285
Link
https://clinicaltrials.gov/show/NCT00415285
Stichworte
Versionen (1)
- 23.01.17 23.01.17 -
Hochgeladen am
23. Januar 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Neoplasms NCT00415285
Eligibility Breast Neoplasms NCT00415285
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Neoplasms NCT00415285
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Breast Carcinoma
Item
histologically or cytologically confirmed breast carcinoma.
boolean
C0678222 (UMLS CUI [1])
Early-Stage Breast Carcinoma TNM clinical staging
Item
early stage breast cancer (stage 1, 2, 3).
boolean
C2986665 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,2])
Disease outside Breast | Disease outside chest wall | Axillary lymph nodes Ipsilateral
Item
no evidence of disease outside the breast or chest wall, except ipsilateral axillary lymph nodes.
boolean
C0012634 (UMLS CUI [1,1])
C0205101 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0205101 (UMLS CUI [2,2])
C1279035 (UMLS CUI [2,3])
C0729594 (UMLS CUI [3,1])
C0441989 (UMLS CUI [3,2])
C0205101 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0205101 (UMLS CUI [2,2])
C1279035 (UMLS CUI [2,3])
C0729594 (UMLS CUI [3,1])
C0441989 (UMLS CUI [3,2])
Age
Item
18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
Eligibility Determination Final Health Professionals
Item
final eligibility for a clinical trial is determined by the health professionals conducting the trial.
boolean
C0013893 (UMLS CUI [1,1])
C3853528 (UMLS CUI [1,2])
C1704312 (UMLS CUI [1,3])
C3853528 (UMLS CUI [1,2])
C1704312 (UMLS CUI [1,3])
Chemotherapy Breast Carcinoma | Hormone Therapy Breast Carcinoma | Biological treatment Breast Carcinoma | Therapeutic radiology procedure Breast Carcinoma
Item
prior chemotherapy, hormonal therapy, biologic therapy or radiation therapy for breast cancer.
boolean
C0392920 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1531518 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4,1])
C0678222 (UMLS CUI [4,2])
C0678222 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1531518 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4,1])
C0678222 (UMLS CUI [4,2])
major surgery
Item
major surgery within 28 days of study entry.
boolean
C0679637 (UMLS CUI [1])
CNS metastases Evidence of
Item
evidence of cns metastases.
boolean
C0686377 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,2])
Eligibility Determination Final Health Professionals
Item
final eligibility for a clinical trial is determined by the health professionals conducting the trial.
boolean
C0013893 (UMLS CUI [1,1])
C3853528 (UMLS CUI [1,2])
C1704312 (UMLS CUI [1,3])
C3853528 (UMLS CUI [1,2])
C1704312 (UMLS CUI [1,3])